Case study
Bringing expert biotech perspectives to the financial press
How we helped BB Biotech demystify its investment strategy and gain visibility with European financial media
Client
BB Biotech
Sector
Asset management
Services
PR and media relations
Challenge
BB Biotech, a listed biotech investment company, needed to improve investor understanding of its portfolio strategy and the broader biotech landscape.
Solution
We helped simplify and communicate the company’s high-conviction investment thesis and long-term perspective to financial journalists unfamiliar with biotech terminology. We built trusted relationships with Tier One European financial press, positioning BB Biotech’s spokespeople as calm, insightful voices amid biotech market volatility.
Result
Media coverage became more frequent, more accurate, and more aligned with BB Biotech’s strategic message. The company saw increased media engagement during earnings cycles and broader visibility across generalist investor titles.
Could this work for you?
Every brief is different, but our goal is always the same: communications that deliver real business value.
If you’d like to find out more about how we can help you achieve your commercial and reputational objectives, get in touch, we’d love to hear from you.
